Corals to cure cancer: new paradigm in early drug development

  • Master tropical coral sourcing, phylogenetic characterization and in-house clonal biomass generation
  • Identify and characterize active molecules of interest for human health
  • Develop these natural molecules as drug candidates, mainly for treatment of rare and incurable cancers, up to the first-in-human clinical trial
  • Negotiate license agreements with pharmaceutical companies to complete the last development steps toward market access, while supplying them with pharmaceutical grade coral biomass

Pioneer company in this innovative drug development model of natural active molecules, CORAL BIOME has already done its proof of concept with the successful development of some highly potent molecules with novel anticancer activity.